Larry Heit, MD
Ophthalmology · Roswell, GANPI 1750388245
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $14,982 of the $24,873 with a category attached, or 60.2%. 31 manufacturers reported payments, led by Alcon at 37.9% of the total. Reporting peaked in 2023 at $6,489 and has fallen 65.9% since, to $2,210 in 2025. Among ophthalmology clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 399 payments — averaging $62.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$9K
- Johnson & Johnson Surgical Vision, Inc.$7K
- Carl Zeiss Meditec USA, Inc.$1K
- Sun Pharmaceutical Industries Inc.$902
- Tarsus Pharmaceuticals, Inc.$794
- AbbVie$721
- plus $4K from 25 others
What the payments were for
- Consulting fees$4,85019%
- Speaking & faculty fees$2,0008%
- Travel & lodging$1,4146%
- Food & beverage$14,98260%
- Education$5182%
- Gifts$1210%
- Entertainment$580%
- Other$9304%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 89 | $9,430 |
| Johnson & Johnson Surgical Vision, Inc. | 89 | $7,488 |
| Carl Zeiss Meditec USA, Inc. | 6 | $1,233 |
| Sun Pharmaceutical Industries Inc. | 26 | $902 |
| Tarsus Pharmaceuticals, Inc. | 29 | $794 |
| AbbVie(2 entities) | 28 | $721 |
| Glaukos Corporation | 9 | $543 |
| Rxsight Inc | 8 | $507 |
| Novartis | 30 | $506 |
| Coopervision Inc. | 2 | $500 |
| Bausch & Lomb Americas Inc. | 11 | $294 |
| Dompe US, Inc. | 9 | $264 |
| Eyevance Pharmaceuticals LLC | 5 | $248 |
| Carl Zeiss Meditec, Inc. | 3 | $219 |
| Amgen(2 entities) | 9 | $190 |
| Harrow Eye, LLC | 6 | $162 |
| Oyster Point Pharma, Inc. | 7 | $141 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 7 | $115 |
| Quidel Corporation | 1 | $95 |
| Kala Pharmaceuticals, Inc. | 5 | $86 |
| Thea Pharma Inc. | 3 | $73 |
| Optos, Inc. | 2 | $58 |
| Aerie Pharmaceuticals, Inc. | 3 | $54 |
| Akorn, Inc. | 2 | $54 |
| Biotissue Holdings Inc. | 3 | $52 |
| Mallinckrodt Hospital Products Inc. | 2 | $35 |
| Shire North American Group Inc | 1 | $25 |
| Ocular Therapeutix, Inc. | 1 | $22 |
| Leadiant Biosciences, Inc. | 1 | $21 |
| Sight Sciences, Inc. | 1 | $21 |
| Astellas Pharma US Inc | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LenSx$5,256
- CATALYS SYSTEM$2,000
- Whitestar Signature Pro$2,000
- Tecnis IOL$1,188
- LUMERA 700$1,099
- Tecnis Simplicity$779
- MiSight Contact Lens$500
- Clareon$431
- AcrySof IQ PanOptix$274
- Clareon PanOptix Pro$252
- Tecnis Symfony IOL$239
- ORA$235
- AcrySof IQ PanOptix UV IOL$186
- Tobradex ST$172
- Centurion$147
- VERITAS Vision System$145
- RXSIGHT CONTACT LENS$144
- RXSIGHT INJECTOR CARTRIDGE$144
- RXSIGHT INJECTOR HANDPIECE$144
- RXSIGHT LIGHT DELIVERY DEVICE (LDD)$144
How this compares
$24,873 in reported general payments places this provider in the 90th percentile of 481 ophthalmology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 119 | $145,275 |
| XdemvyLotilaner | 36 | $67,887 |
| LumiganBimatoprost | 80 | $51,962 |
| XiidraLifitegrast | 21 | $29,254 |
| Cyclosporine | 16 | $16,831 |
| CombiganBrimonidine Tartrate/Timolol | 26 | $14,658 |
| Travoprost | 25 | $7,516 |
| Latanoprost | 531 | $7,069 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 13 | $4,013 |
| Timolol Maleate | 229 | $2,241 |
| Prednisolone Acetate | 73 | $2,181 |
| Brimonidine Tartrate | 20 | $1,858 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 188 | $1,777 |
| Dorzolamide-TimololDorzolamide/Timolol/Pf | 11 | $1,650 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 68 | $1,599 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRestasis, Lumigan, Combigan | $721 | $211,895225 claims |
| Tarsus Pharmaceuticals, Inc.Xdemvy | $794 | $67,88736 claims |
| Bausch & Lomb Americas Inc.Xiidra | $294 | $29,25421 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 481 ophthalmology providers in Georgia.
Other ophthalmology in Roswell
- Gagan SawhneyAtlanta$582K
- Lawrence WoodardAtlanta$578K
- Stephanie VanderveldtAtlanta$384K
- Steven YehAtlanta$289K
- Jack ChapmanGainesville$244K
- Gregory LeeCumming$214K
- Puneet PandaMarietta$185K
- Jeffrey TranSuwanee$150K
- Evan SchoenbergAtlanta$130K
- Niraj DesaiCumming$129K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.